Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis

被引:104
作者
Hunter, Sonja G.
Zhuang, Guanglei
Brantley-Sieders, Dana
Swat, Wojciech
Cowan, Christopher W.
Chen, Jin
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[5] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[6] Harvard Univ, Sch Med, Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
关键词
D O I
10.1128/MCB.02215-05
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis, the process by which new blood vessels are formed from preexisting vasculature, is critical for vascular remodeling during development and contributes to the pathogenesis of diseases such as cancer. Prior studies from our laboratory demonstrate that the EphA2 receptor tyrosine kinase is a key regulator of angiogenesis in vivo. The EphA receptor-mediated angiogenic response is dependent on activation of Rho family GTPase Rac1 and is regulated by phosphatidylinositol 3-kinase. Here we report the identification of Vav2 and Vav3 as guanine nucleotide exchange factors (GEFs) that link the EphA2 receptor to Rho family GTPase activation and angiogenesis. Ephrin-A1 stimulation recruits the binding of Vav proteins to the activated EphA2 receptor. The induced association of EphA receptor and Vav proteins modulates the activity of Vav GEFs, leading to activation of Rac1 GTPase. Overexpression of either Vav2 or Vav3 in primary microvascular endothelial cells promotes Rac1 activation, cell migration, and assembly in response to ephrin-A1 stimulation. Conversely, loss of Vav2 and Vav3 GEFs inhibits Rac1 activation and ephrin-A1-induced angiogenic responses both in vitro and in vivo. In addition, embryonic fibroblasts derived from Vav2(-/-) Vav3(-/-) mice fail to spread on an ephrin-A1-coated surface and exhibit a significant decrease in the formation of ephrin-A1-induced lamellipodia and filopodia. These findings suggest that Vav GEFs serve as a molecular link between EphA2 receptors and the actin cytoskeleton and provide an important mechanism for EphA2-mediated angiogenesis.
引用
收藏
页码:4830 / 4842
页数:13
相关论文
共 50 条
[1]   Vav2 is an activator of Cdc42, Rac1, and RhoA [J].
Abe, K ;
Rossman, KL ;
Liu, B ;
Ritola, KD ;
Chiang, D ;
Campbell, SL ;
Burridge, K ;
Der, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10141-10149
[2]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[3]   Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells [J].
Aoki, K ;
Nakamura, T ;
Fujikawa, K ;
Matsuda, M .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (05) :2207-2217
[4]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[5]   A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis [J].
Bin Fang, W ;
Brantley-Sieders, DM ;
Parker, MA ;
Reith, AD ;
Chen, J .
ONCOGENE, 2005, 24 (53) :7859-7868
[6]   Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors [J].
Binns, KL ;
Taylor, PP ;
Sicheri, F ;
Pawson, T ;
Holland, SJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) :4791-4805
[7]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[8]   Eph receptor tyrosine kinases in tumor and tumor microenvironment [J].
Brantley-Sieders, D ;
Schmidt, S ;
Parker, M ;
Chen, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (27) :3431-3442
[9]   Eph receptor tyrosine kinases in angiogenesis: From development to disease [J].
Brantley-Sieders D.M. ;
Chen J. .
Angiogenesis, 2004, 7 (1) :17-28
[10]   Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression [J].
Brantley-Sieders, DM ;
Fang, WB ;
Hicks, DJ ;
Zhuang, GL ;
Yu, S ;
Chen, J .
FASEB JOURNAL, 2005, 19 (11) :1884-+